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Abstract
Fanconi anemia (FA) is an inherited disorder of genomic instability associated with high risk of 
myelodysplasia and AML. Young mice deficient in FA core complex genes do not naturally 
develop cancer, hampering preclinical studies on malignant hematopoiesis in FA. Here we show 
that aging Fancc−/− mice are prone to genomically unstable AML and other hematologic 
neoplasms. We demonstrate that aneuploidy precedes malignant transformation during Fancc−/− 
hematopoiesis. Our observations reveal that Fancc−/− mice develop hematopoietic chromosomal 
instability followed by leukemia in age-dependent manner, recapitulating the clinical phenotype of 
human Fanconi anemia and providing a proof of concept for future development of preclinical 
models of FA-associated leukemogenesis.
INTRODUCTION
The Fanconi anemia (FA) signaling network protects genomic integrity and prevents cancer 
by facilitating interphase DNA repair and orchestrating cell division1-3. Germline biallelic 
mutations of any FA genes cause Fanconi anemia (FA), an inherited bone marrow failure 
syndrome associated with myelodysplasia (MDS) and acute myeloid leukemia (AML). The 
overall risk of leukemia in FA is increased 600-fold4.
Young mice deficient in core FA genes do not spontaneously recapitulate clinical 
hematopoietic manifestations of Fanconi anemia5. Fancc−/− mice demonstrate 
hypersensitivity to cross-linking agents6, decreased hematopoietic stem cell repopulating 
ability7,8, and hypersensitivity to interferon-gamma8 reflecting disruption of the FA 
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signaling network during hematopoiesis. However, young Fancc−/− mice do not develop 
spontaneous leukemia or bone marrow failure6,8. One observation study of a small Fancc−/− 
mouse cohort (n=8) did not detect decreased survival9. However, FA patients very rarely 
develop AML in their first year of life10 and two soft-tissue tumors (adenocarcinoma and 
histiocytic sarcoma) had been reported in >13-month old Fancc−/− mice11. Thus, we 
hypothesized that aging Fancc−/− mice may be predisposed to hematopoietic malignancies. 
If the absolute time to the onset of leukemia is similar in FA humans and mice, a long-term 
observation of FA−/− mice may be crucial to detect cancer predisposition. To address this 
translationally relevant question, we asked whether Fancc−/− mice develop malignancies as 
they age.
RESULTS & DISCUSSION
We observed cohorts of wt (n=20) and Fancc−/− (n=18) mice for 24 months, and noticed 
decreased survival of Fancc−/− mice (p=0.01, Fig. 1A). Five Fancc−/− mice (27.8%) died 
between 8 and 24 months of age due to leukemia or lymphoma (Fig. 1B-L). Specifically, we 
diagnosed acute myeloid leukemia (AML) in two moribund Fancc−/− mice with peripheral 
blasts, predominance of Gr-1+ (Ly-6G) peripheral blood low-density mononuclear cells 
(LDMNCs), and myeloid infiltrates around the liver vessels (Fig. 1C-E). One Fancc−/− 
mouse developed lethal B-cell acute lymphoblastic leukemia (ALL), as evidenced by 
expansion of B220+ blasts that replaced >90% of bone marrow and infiltrated the liver (Fig. 
1F-H). Additionally, two Fancc−/− mice died due to metastatic abdominal T-cell lymphoma 
manifested by massive mesenteric lymph node conglomerates (Fig. 1I-J) accompanied by 
Cd3+ liver infiltrates (Fig. 1K-L) in the absence of bone marrow or peripheral blood 
abnormalities. After 24 months of observation, all surviving Fancc−/− and wt mice were 
sacrificed and examined by necropsy. 4/13 (30.8%) 2-year old Fancc−/− animals had 
hematopoietic solid tumors and/or peripheral blasts, consistent with leukemia/lymphoma. 
Serial blood counts did not reveal progressive pancytopenia in aging Fancc−/− mice, 
suggesting that the development of leukemia may not be preceded by bone marrow failure in 
this animal model of FA. Together, 9/18 Fancc−/− mice developed hematopoietic 
malignancies by two years of age (including 5 animals that died prematurely due to disease), 
compared to 0/20 control wt mice (Fig. 1B, p=0.0003). Thus, aging Fancc−/− mice are 
prone to hematopoietic neoplasms, reflecting the age-dependent risk of leukemia in FA 
patients4,10,12.
We next asked whether Fancc−/− AML can be propagated in wt mice via competitive stem 
cell transplantation. We mixed donor Fancc−/− Cd45.2+ LDMNCs isolated from a moribund 
AML Fancc−/− mouse (Fig. 1C-E) with wt Cd45.1+ competitor LDMNCs at a 1:1 ratio and 
transplanted the mixed cells into 3 lethally irradiated wt recipients. Three wt recipients of 
age-matched wt Cd45.2+ LDMNCs mixed with wt Cd45.1+ LDMNCs served as controls 
(Fig. 2A). By 50 days post-transplantation, all recipients of Fancc−/− LDMNCs had died of 
AML, while control recipients of wt LDMNCs remained healthy (Fig. 2B). The diagnosis of 
AML was confirmed in all recipients by flow cytometry, peripheral blood smears (Fig. 2C) 
and splenomegaly (p=0.0216, Fig. 2D). Peripheral blood flow cytometry demonstrated 
increased Cd45.2+ chimerism (p=0.0436) in recipients of leukemic Fancc−/− LDMNCs 
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compared to controls at one month post-transplant (Fig. 2E-F), highlighting the malignant 
potential of leukemic Fancc−/− LDMNCs to outcompete wt hematopoietic cells in the host 
marrow.
The FA signaling network maintains genomic integrity during Fancc−/− hematopoiesis in 
vivo13 and genomic instability promotes cancer14. Thus, we asked whether leukemic Fancc
−/− mice displayed increased chromosomal instability and whether chromosomal instability 
precedes the onset of leukemia during Fancc−/− hematopoiesis. We compared karyotypes of 
LDMNCs isolated from leukemic Fancc−/− to age-matched wt and healthy Fancc−/− 
marrows. Bone marrow cells isolated from healthy Fancc−/− mice had higher incidence of 
aneuploidy and increased frequency of abnormal mitotic figures than wt LDMNCs (Fig. 3A-
D), showing that Fancc−/− hematopoietic cells become chromosomally unstable before overt 
leukemogenesis occurs. Similarly, FA patients develop hematopoietic chromosomal and 
nuclear abnormalities prior to the onset of leukemia13,15,16. Leukemic Fancc−/− bone 
marrows were more aneuploid (Fig. 3B) with higher mitotic index compared to both age-
matched wt (p=0.001) and Fancc−/− non-leukemic marrows (p<0.0001, Fig. 3D). This 
observation is consistent with further exacerbation of genomic instability and acquisition of 
bizarre karyotypic abnormalities reported in human FA-associated AML17,18.
In summary, Fancc−/− mice develop chromosomally unstable hematopoietic malignancies as 
they age, recapitulating clinical and genomic abnormalities seen in Fanconi anemia patients 
(Figs. 1 and 3). Interestingly, similar incidence of tumors had been reported in old mice 
deficient in another FA core gene, Fanca, although that observation did not reach statistical 
significance due to small sample sizes19. Thus, late-onset carcinogenesis may be a common 
phenotype of murine FA core gene knockouts. AML arising in Fancc−/− mice can be 
propagated via hematopoietic stem cell transplant and produce rapid onset of lethal leukemia 
in wt transplant recipients (Fig. 2). As large-scale cohorts of leukemic mice are essential for 
preclinical drug testing, our observations may facilitate the development of future preclinical 
models of FA−/− AML.
METHODS
Mice
C57Bl/6J Fancc−/− mice were a gift of David W. Clapp (Indiana University). Mice were 
PCR-genotyped as described9. B6.SJL-PtprcaPepcb/BoyJ mice were purchased from the IU 
In Vivo Therapeutics Core. All studies were approved by the Institutional Animal Care and 
Use Committee at IU.
Marrow harvest and transplantation
Bone marrow cells were flushed from mouse femurs using a 23-gauge needle/syringe 
(Becton Dickinson). LDMNCs were isolated by density gradient using Histopaque-1119 
(Sigma) centrifuging for 30 minutes at 1800rpm with no brake. After centrifugation, 
LDMNCs were removed from the interface and utilized for experiments. Cytospins were 
made by resuspending LDMNCs in PBS and centrifuging onto slides at 450rpm for 5 
minutes on a Shandon Cytospin 3 Cytocentrifuge (Thermo Scientific). 1.5×106 donor test 
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LDMNCs (C57Bl/6J background) and 1.5×106 donor competitor BoyJ LDMNCs were 
transplanted into recipients via tail vein injection. Recipients were 8 week-old female 
B6.SJL-PtprcaPepcb/BoyJ mice that underwent whole-body split-dose 1100 rads irradiation 
(700 rads/400 rads, 4 hours apart). For chimerism analysis, peripheral blood was collected 
from lateral tail veins into EDTA-coated tubes, incubated with RBC lysis solution (Qiagen) 
for 10 minutes at room temperature, washed, stained with anti-Cd45.2-FITC (BD 
Biosciences) and anti-Cd45.1-PE (BD Biosciences) as described9, and analyzed on a 
FacsCalibur machine (Becton-Dickinson). At least 10,000 events/sample were acquired and 
analyzed using FlowJo Software.
Metaphase spreads
Bone marrow cells flushed from tibias were cultured in IMDM plus 20% FBS, murine SCF 
(100ng/ml), and IL-6 (200ng/ml) for 2 days. Cells were then exposed to 0.2 μg/ml colcemid 
(Life Tech) for 4 hours and pelleted at 800rpm for 5 minutes. Cells were resuspended 
dropwise in pre-warmed (37°C) 75mM KCl, and incubated at 37°C for 15 minutes. After 
pelleting, cells were resuspended in a 3:1 methanol:glacial acetic acid fixative. Cells were 
pelleted and resuspended in fixative two additional times before being dropped onto slides 
and dried overnight. Spreads were stained with Vectashield mounting medium with DAPI 
(Vector Laboratories).
Histology and flow cytometry
Murine tissues obtained post-mortem were fixed in 10% formalin, paraffin-embedded, 
sectioned (5 μM sections), and stained with hematoxylin and eosin. Peripheral blood smears 
and bone marrow cytospins were stained with Giemsa using the automated Siemens 
Hematek 3000 (Fisher) system. For flow cytometry, peripheral blood cells were incubated in 
RBC lysis solution and bone marrow LDMNCS were isolated as described above. Cells 
were stained with either Gr-1-APC (Ly6G, clone: RB6-8C5) or B220-FITC (clone: 
RA3-6B2), analyzed on a FacsCalibur machine using live gating followed by data 
quantification with FlowJo software. Leukemia diagnoses were made using criteria 
established in the Bethesda proposal for classification of nonlymphoid neoplasms in mice20, 
and were independently validated by a veterinary pathologist at IU School of Medicine.
Microscopy
Images of smears, cytospins, and histological sections were obtained using a Zeiss Axiolab 
microscope with a color camera. Metaphase spreads were imaged on a Deltavision 
personalDx deconvolution microscope (Applied Precision). Image stacks (distance between 
z-sections: 0.2 μm) were deconvolved using Softworx and analyzed using Imaris software 
suite (Bitplane).
Statistics
Statistical analysis was performed with the GraphPad Prism 6 software.
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Fig 1. Aging Fancc−/− mice develop hematologic malignancies
(A) Kaplan-Meier survival curve of wt (n=20) and Fancc−/− (n=18) cohorts. (B) Table 
demonstrating incidence of leukemias and lymphomas in wt and Fancc−/− mice by 24 
months of age. Statistical significance for (A, B) was determined using a log-rank (Mantel-
Cox) test. Peripheral blood smear of a moribund Fancc−/− mouse (C) shows leukemic blasts 
(arrows). Diagnosis of acute myeloid leukemia was confirmed with flow cytometry 
demonstrating increased expression of the Gr1 myeloid marker in the peripheral blood 
compared to wt and healthy Fancc−/− controls (D) and the presence of leukemic infiltrates 
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in the liver (E). Bone marrow cytospin (F) of another moribund Fancc−/− mouse 
demonstrated multiple blasts (arrows). Flow cytometry demonstrated increased expression of 
the B220 B-cell marker on bone marrow blasts (G) and necropsy revealed leukemic 
infiltrates in the liver (H), consistent with B-cell ALL. Necropsy of another Fancc−/− mouse 
demonstrated conglomerates of mesenteric lymph nodes (I, J). Liver infiltrates in this mouse 
were Cd3+ (K, L), consistent with T-cell lymphoma.
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Fig 2. Transplanted Fancc−/− AML LDMNCs induce aggressive leukemia in wt recipients
(A) Competitive repopulation transplant schematic. Cd45.2+ LDMNCs obtained from a 
leukemic Fancc−/− mouse or wt control were mixed 1:1 with Cd45.1+ wt competitor 
LDMNCs and transplanted into lethally irradiated wt recipients (n=3 recipients per 
genotype). (B) Recipients of Fancc−/− LDMNCs died within 2 months after transplantation. 
Log-rank (Mantel-Cox) test was used to assess significance. (C) AML in wt recipients of 
Fancc−/− LDMNCs. Gr1 was used as a myeloid marker for flow cytometry (right panel). 
(D) Splenomegaly in moribund wt mice transplanted with Fancc−/− LDMNCs. (E, F) 
Leukemic Cd45.2+ Fancc−/− LDMNCs overpopulate recipient bone marrow compared to wt 
Cd45.1+ competitor LDMNCs. Statistical significance was determined using an unpaired 
student's t-test; error bars represent SEM.
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Fig 3. Genomic instability and abnormal mitosis in leukemic and pre-leukemic Fancc−/− mice
(A) Representative images of LDMNC metaphase spreads from wt and leukemic Fancc−/− 
mice. (B) Increased aneuploidy in leukemic Fancc−/− LDMNCs. At least 74 spreads were 
counted from wt, Fancc−/− non-leukemic, and Fancc−/− leukemic mice. Note increased 
chromosomal instability in non-leukemic Fancc−/− LDMNCs compared to age-matched wt 
controls. Fisher's exact test was used to determine statistical significance. Leukemic Fancc−/
− LDMNCs undergo abnormal mitosis (C) and have a higher mitotic index (D) compared to 
LDMNCs from wt and Fancc−/− non-leukemic mice (n=3 mice/genotype; at least 500 cells 
were counted per genotype). Statistical analyses were performed using chi-square tests with 
Yates correction.
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